Publisher's Synopsis
Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Levocetirizine Editorial: "The classification of allergic rhinitis has recently been revised and the disease is now categorised as either intermittent or persistent." Disease Overview: "Allergic rhinitis is an extremely prevalent disease, affecting 10-20% of the UK population and over 10% of the world's population." Drug Review: "Levocetirizine has twice the potency of cetirizine in attenuating histamine-induced wheal, flare and itch reactions, and is more potent than other antihistamines (ebastine, fexofenadine, loratadine, mizolastine) at their recommended doses." Improving Practice: "Clearly, allergic rhinitis is not a trivial complaint. It can radically change and, on occasion take over the lives of our patients."
